Meaningful suffixes are important in medicine. That’s why 80% of doctors prefer them for biosimilar naming as well.
The FDA is considering naming biosimilar medicines with a random code versus a more recognizable name. In a recent SERMO* poll, representing over 500 physicians across multiple specialties, 80% of physicians prefer a “meaningful suffix.” Physician groups across the country call for biosimilar names that are easily distinguished and recognized.
*SERMO is the largest global social network exclusively for doctors.
